Rita Lemming

UP-NEXT (GOG-3049/ENGOT-Ov71-NSGO-CTU): A study of upitifamab rilsodotin (UpRi), a NaPi2b-directed antibody drug conjugate (ADC), in platinum-sensitive recurrent ovarian cancer.

T. Herzog, M. Mirza, P. Harter, 2023, Journal of Clinical Oncology.